Logo image of OPT

OPTHEA LTD-SPON ADR (OPT) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:OPT - US68386J2087 - ADR

3.41 USD
+0.23 (+7.23%)
Last: 3/17/2025, 8:00:02 PM
Fundamental Rating

2

OPT gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 528 industry peers in the Biotechnology industry. OPT may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, OPT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year OPT has reported negative net income.
In the past year OPT has reported a negative cash flow from operations.
In the past 5 years OPT always reported negative net income.
In the past 5 years OPT always reported negative operating cash flow.
OPT Yearly Net Income VS EBIT VS OCF VS FCFOPT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50M -100M -150M -200M

1.2 Ratios

Looking at the Return On Assets, with a value of -175.60%, OPT is doing worse than 86.49% of the companies in the same industry.
Industry RankSector Rank
ROA -175.6%
ROE N/A
ROIC N/A
ROA(3y)-138.57%
ROA(5y)-94.2%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OPT Yearly ROA, ROE, ROICOPT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K 1.5K 2K

1.3 Margins

OPT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OPT Yearly Profit, Operating, Gross MarginsOPT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50K -100K -150K

More info and screens

1

2. Health

2.1 Basic Checks

OPT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OPT has more shares outstanding
Compared to 5 years ago, OPT has more shares outstanding
OPT has a worse debt/assets ratio than last year.
OPT Yearly Shares OutstandingOPT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
OPT Yearly Total Debt VS Total AssetsOPT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

OPT has an Altman-Z score of -9.32. This is a bad value and indicates that OPT is not financially healthy and even has some risk of bankruptcy.
OPT has a worse Altman-Z score (-9.32) than 71.05% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -9.32
ROIC/WACCN/A
WACC9.32%
OPT Yearly LT Debt VS Equity VS FCFOPT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

A Current Ratio of 1.57 indicates that OPT should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.57, OPT is doing worse than 81.23% of the companies in the same industry.
A Quick Ratio of 1.57 indicates that OPT should not have too much problems paying its short term obligations.
The Quick ratio of OPT (1.57) is worse than 80.35% of its industry peers.
Industry RankSector Rank
Current Ratio 1.57
Quick Ratio 1.57
OPT Yearly Current Assets VS Current LiabilitesOPT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

5

3. Growth

3.1 Past

OPT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.42%, which is quite good.
OPT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -25.06%.
The Revenue has been growing slightly by 2.88% on average over the past years.
EPS 1Y (TTM)16.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.76%
Revenue 1Y (TTM)-25.06%
Revenue growth 3Y22.04%
Revenue growth 5Y2.88%
Sales Q2Q%-60.45%

3.2 Future

Based on estimates for the next years, OPT will show a very strong growth in Earnings Per Share. The EPS will grow by 24.88% on average per year.
Based on estimates for the next years, OPT will show a very strong growth in Revenue. The Revenue will grow by 384.85% on average per year.
EPS Next Y56.03%
EPS Next 2Y33.14%
EPS Next 3Y24.08%
EPS Next 5Y24.88%
Revenue Next Year-37%
Revenue Next 2Y1620.09%
Revenue Next 3Y1036.13%
Revenue Next 5Y384.85%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
OPT Yearly Revenue VS EstimatesOPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
OPT Yearly EPS VS EstimatesOPT Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 -2 4 6 8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OPT. In the last year negative earnings were reported.
Also next year OPT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OPT Price Earnings VS Forward Price EarningsOPT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OPT Per share dataOPT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5

4.3 Compensation for Growth

OPT's earnings are expected to grow with 24.08% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.14%
EPS Next 3Y24.08%

More info and screens

0

5. Dividend

5.1 Amount

OPT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OPTHEA LTD-SPON ADR

NASDAQ:OPT (3/17/2025, 8:00:02 PM)

3.41

+0.23 (+7.23%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-28 2025-02-28/bmo
Earnings (Next)08-28 2025-08-28/amc
Inst Owners40.24%
Inst Owner Change0%
Ins Owners1.22%
Ins Owner ChangeN/A
Market Cap524.75M
Revenue(TTM)87.90K
Net Income(TTM)-255.97M
Analysts78
Price Target6.57 (92.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3%
PT rev (3m)19.52%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-75.68%
EPS NY rev (3m)-59.98%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-20%
Revenue NY rev (3m)-40%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5969.9
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2
EYN/A
EPS(NY)-0.62
Fwd EYN/A
FCF(TTM)-1.07
FCFYN/A
OCF(TTM)-1.07
OCFYN/A
SpS0
BVpS-1.1
TBVpS-1.1
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -175.6%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-138.57%
ROA(5y)-94.2%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 48.01%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.57
Quick Ratio 1.57
Altman-Z -9.32
F-Score1
WACC9.32%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)21.93%
Cap/Sales(5y)17.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.76%
EPS Next Y56.03%
EPS Next 2Y33.14%
EPS Next 3Y24.08%
EPS Next 5Y24.88%
Revenue 1Y (TTM)-25.06%
Revenue growth 3Y22.04%
Revenue growth 5Y2.88%
Sales Q2Q%-60.45%
Revenue Next Year-37%
Revenue Next 2Y1620.09%
Revenue Next 3Y1036.13%
Revenue Next 5Y384.85%
EBIT growth 1Y-10.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1.69%
EBIT Next 3Y15.54%
EBIT Next 5Y22.71%
FCF growth 1Y-46.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-46.8%
OCF growth 3YN/A
OCF growth 5YN/A

OPTHEA LTD-SPON ADR / OPT FAQ

Can you provide the ChartMill fundamental rating for OPTHEA LTD-SPON ADR?

ChartMill assigns a fundamental rating of 2 / 10 to OPT.


Can you provide the valuation status for OPTHEA LTD-SPON ADR?

ChartMill assigns a valuation rating of 1 / 10 to OPTHEA LTD-SPON ADR (OPT). This can be considered as Overvalued.


How profitable is OPTHEA LTD-SPON ADR (OPT) stock?

OPTHEA LTD-SPON ADR (OPT) has a profitability rating of 0 / 10.


How financially healthy is OPTHEA LTD-SPON ADR?

The financial health rating of OPTHEA LTD-SPON ADR (OPT) is 1 / 10.


Can you provide the expected EPS growth for OPT stock?

The Earnings per Share (EPS) of OPTHEA LTD-SPON ADR (OPT) is expected to grow by 56.03% in the next year.